Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Cytosorbents Corporation (NASDAQ: CTSO)
CTSO Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
19.30%
Analyst Rating:
BUY
Analyst Forecast (1yr):
400%
CTSO Stock Analysis
CTSO
PE Ratio:
CTSO
PEG Ratio:
Not Available
CTSO
Forward EPS Growth (12 month):
0.00%
CTSO
PS Ratio:
0.8
CTSO
PSG Ratio:
CTSO
Forward Revenue Growth (12 month):
25.10%
CTSO Articles
No data was found